Roche says US OKs Tamiflu for prevention in young

U.S. regulators approved Roche AG’s request to market antiviral drug Tamiflu for preventing influenza in children ages 1 through 12, the company said on Wednesday.

Tamiflu is being stockpiled by countries in case of an avian flu pandemic in people. The drug previously was approved for preventing infection in adults and adolescents age 13 and older and for treating the flu in anyone 1 year old or older.

Print Version
Tell-a-Friend comments powered by Disqus

RELATED ARTICLES:

New biomarkers may influence drug design and alternative treatments of cancer, study shows   UGA ecologist finds another cause of antibiotic resistance   New drug for neuroblastoma shows promise in phase I study   Baclofen shows promise in patients with alcohol-induced liver disease   Findings point to an ‘off switch’ for drug resistance in cancer   Stopping statins may benefit terminally ill patients   Cholesterol drug users may use pills as a license to overeat   Pfizer lung cancer drug beats chemo for previously untreated patients   Mass. General study identifies path to safer drugs for heart disease, cancer   Gates Foundation awards Notre Dame $23 million for malaria, dengue studies   Cancer drug protects against diabetes   Malaria drug target raises hopes for new treatments